WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017062974) USE OF MEDICATIONS WITH NEUROPROTECTIVE PROPERTIES TO PREVENT OR REDUCE THE RISK OF ISCHEMIA-REPERFUSION INJURY IN A SUBJECT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/062974 International Application No.: PCT/US2016/056341
Publication Date: 13.04.2017 International Filing Date: 11.10.2016
IPC:
A61P 25/28 (2006.01) ,A61P 25/00 (2006.01) ,A61K 31/57 (2006.01)
Applicants: VRABEC, Tamara[US/US]; US
Inventors: VRABEC, Tamara; US
Agent: NGUYEN, Quang D.; US
GHIDU, Victor; US
NGUYEN, Quang, D.; US
ALLEN, Justin; US
ARTIS, Ryan; US
Priority Data:
15/193,62527.06.2016US
62/239,63909.10.2015US
Title (EN) USE OF MEDICATIONS WITH NEUROPROTECTIVE PROPERTIES TO PREVENT OR REDUCE THE RISK OF ISCHEMIA-REPERFUSION INJURY IN A SUBJECT
(FR) UTILISATION DE MÉDICAMENTS DOTÉS DE PROPRIÉTÉS NEUROPROTECTRICES POUR LA PRÉVENTION OU LA RÉDUCTION DU RISQUE DE LÉSION D'ISCHÉMIE-REPERFUSION CHEZ UN PATIENT
Abstract: front page image
(EN) Provided are methods for treatment and prevention of ischemia- reperfusion injury and chronic intermittent hypoxia related injury through administering a neuroprotective compound. A subject benefiting from the method of the invention may be prescribed or undergoing anti-VEGF treatment, for example an IV AV treatment regimen, or may be diagnosed with a disorder such as sleep apnea.
(FR) L'invention concerne des méthodes de traitement et de prévention d'une lésion d'ischémie-reperfusion et d'une lésion liée à une hypoxie intermittente chronique, par l'administration d'un composé neuroprotecteur. Un patient bénéficiant de la méthode de l'invention peut se voir prescrit ou administré un traitement anti-VEGF, par exemple un régime thérapeutique IV AV, ou peut être diagnostiqué comme atteint d'un trouble tel que l'apnée du sommeil.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)